NCT02881710View on ClinicalTrials.gov

Variation IGFBP7 Markers and TIMP2 Induced by Injection of Contrast Iodized Drug at the Intensive Care Patient

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 9, 2014

Primary Completion Date

March 27, 2016

Study Completion Date

March 27, 2016

Conditions
Emergency
Interventions
OTHER

contrast product used to assess biomarkers variations

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT02881710 - Variation IGFBP7 Markers and TIMP2 Induced by Injection of Contrast Iodized Drug at the Intensive Care Patient | Biotech Hunter | Biotech Hunter